ARCHIVES

“Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.”

This article is from The Cancer Letter archive.

Vol. 21 No. 27 | July 7, 1995

Download PDF Visit The Full Archive

Related Articles

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

In Brief: FDA Approves G-CSF For Marketing; Walkmann Wins Belgian Health Prize; Green To Head NWTS

March 1, 1991

Emerging Technologies: Company To Expand Program Studying Polymer Platinates

June 1, 2001

EU Gives Marketing Approval For HBV Sequencing Test

April 29, 2011

NCI Prepares To Dispense A Torrent Of New Money For Cancer Research.

March 6, 2009

Review Of Cancer, AIDS Drugs Starts At Jan. Meeting

December 2, 1988